logo

For the Inventor, By the Inventor

Wellington, New Zealand

Victoria Link Limited

USPTO Granted Patents = 53

% Expired Patents = 26.4



Trademarks = 7

Forward Citations = 46

Loading Chart...
Loading Chart...

125 inventors (with patents filed for the assignee):

goldMedal Peter Charles Tyler (12 out of 38 patents)

silverMedal Vern L Schramm (8 out of 47 patents)

bronzeMedal Gary Brian Evans (7 out of 19 patents)

4.  Keith Clinch (4 out of 11 patents)

5.  Shivali Ashwin Gulab (4 out of 5 patents)

6.  Olga Vladimirovna Zubkova (4 out of 6 patents)

7.  Regan James Anderson (4 out of 4 patents)

8.  Benjamin Jason Compton (4 out of 4 patents)

9.  Colin Malcolm Hayman (4 out of 4 patents)

10.  Ian Francis Hermans (4 out of 4 patents)

11.  Gavin Frank Painter (4 out of 6 patents)

12.  Thomas Edward Prisinzano (3 out of 10 patents)

13.  Jeremy E Turnbull (3 out of 5 patents)

14.  David Samuel Larsen (3 out of 11 patents)

15.  David Francis Ackerley (3 out of 8 patents)


Core Competencies:
Superconducting Switches
MRI Magnet
Dendritic Compounds
Bacterial Infections
Electrolyte Compositions
Agonists
NMR Apparatus
Sphingoglycolipid Analogues
Optical Fibre Sensing
Heparan Sulfate
Ammonia Production
Cluster Analysis

53 patents:

1. 12568774 - Superconducting switches (2026-03-03),
2. 12512461 - Cathode (2025-12-30),
3. 12439833 - Superconducting switch (2025-10-07),
4. 12318380 - Treatment of demyelinating diseases (2025-06-03),
5. 12288911 - Electrolyte compositions (2025-04-29),
6. 12258304 - Compounds and methods for treatment of bacterial infections (2025-03-25),
7. 12196631 - Optical fibre sensing system and method (2025-01-14),
8. 12075776 - Synthetic lures (2024-09-03),
9. 11867780 - MRI magnet and apparatus (2024-01-09),
10. 11651049 - Cluster analysis based on tangles in abstract separations systems (2023-05-16),
11. 11518779 - Inhibitors of DNMT1 as anticancer therapeutic agents (2022-12-06),
12. 11510980 - Brartemicin analogues (2022-11-29),
13. 11498844 - Ammonia production method and apparatus for ammonia production (2022-11-15),
14. 11453882 - Heterologous biosynthesis of nodulisporic acid (2022-09-27),
15. 11324742 - Treatment of demyelinating diseases (2022-05-10),
Company Overview
Victoria Link Limited, based in Wellington, New Zealand, specializes in advanced biomedical applications. The company focuses on developing innovative technologies such as superconducting switches and MRI magnets, which enhance imaging capabilities in medical diagnostics. Their research extends to dendritic compounds and sphingoglycolipid analogues, addressing critical challenges in bacterial infections and electrolyte compositions. Victoria Link is committed to advancing healthcare solutions through cutting-edge research and development in the biomedical field.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

53 Patents

#3 in Wellington

#11 in New Zealand

#13,348 in the World

Wellington, NZ
Wellington, New Zealand

Victoria Link Limited

Forward Citations = 46

125 inventors:

goldMedal Peter Charles Tyler (12 out of 38 patents)

silverMedal Vern L Schramm (8 out of 47 patents)

bronzeMedal Gary Brian Evans (7 out of 19 patents)

4.  Keith Clinch (4 out of 11 patents)

5.  Shivali Ashwin Gulab (4 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Victoria Link Limited. Retrieved from https://idiyas.com/company/victoria-link

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…